Back to results
US 9,102,913 B2Granted
Biomatrix scaffolds for industrial scale dispersal
AssigneesThe University of North Carolina at Chapel Hill, PhoenixSongs Biologicals
InventorsMarsha Lynn Roach, Richard Harold Malavarca, Yunfang Wang, Lola Cynthia McAdams Reid
Life of this patent
Estimating the term…
Abstract
The present invention provides biomatrix scaffolds for industrial scale dispersal.
Claims18
A method of producing a biomatrix scaffold from biological tissue for industrial scale dispersal onto culture apparatus, comprising:
- (a) perfusing or homogenizing biological tissue with a buffer comprising a salt concentration from about 3.5 M NaCl to about 4.5 M NaCl, wherein the tissue is selected from the group consisting of liver, lung, thyroid, skin, pancreas, blood vessels, bladder, kidneys, brain, biliary tree, duodenum, abdominal aorta, iliac vein, heart and intestines;
- then
- (b) perfusing the biological tissue or extracting the homogenate of step (a) with a delipidating buffer comprising lipases and detergents in a serum free first medium, having a neutral pH and an osmolality from about 250 mOsm/kg to about 350 mOsm/kg, wherein the detergents do not comprise sodium dodecyl sulfate or TritonX-100;
- then
- (c) perfusing the tissue or extracting the homogenate of step (b) with a buffer at a neutral pH and comprising a salt concentration from about 2.0 M NaCl to about 5.0 M NaCl, the concentration chosen to keep insoluble collagens identified in the biological tissue;
- then
- (d) perfusing the tissue or extracting the homogenate of step (c) with RNase and DNase in a buffer;
- and then
- (e) rinsing the tissue or homogenate of step (d) with a second medium that is at neutral pH, is serum-free and has an osmolality from about 250 mOsm/kg to about 350 mOsm/kg, thereby producing an intact or homogenized biomatrix scaffold from the biological tissue, said biomatrix scaffold comprising at least 95% of the collagens and most collagen-associated matrix components and matrix bound growth factors, hormones and cytokines of the biological tissue;
- (f) diluting the biomatrix scaffold in basal medium;
- (g) freezing the biomatrix scaffold of (f);
- (h) pulverizing the biomatrix scaffold of (g) by cryogenic grinding into biomatrix particles ranging in size from about 1 nm to about 100 μm;
- (i) thawing the biomatrix particles of (h) in suspension in basal medium;
- and
- (j) dispersing the biomatrix particles of step (i) onto a culture apparatus, thereby producing a biomatrix scaffold from biological tissue for industrial scale dispersal onto culture apparatus.
12 more elements
Dependencies are inferred from the claim text.